ESC Premium Access

Up to two-year outcomes from the multicenter CE trial of transcatheter mitral valve repair in patients with functional mitral regurgitation

Congress Presentation

About the speaker

Doctor Azeem Latib

Montefiore Medical Center (Bronx), New York (United States of America)
11 presentations
0 follower

5 more presentations in this session

Safety and feasibility of an early ambulation protocol after transfemoral transcatheter aortic valve implantation: results of the early mobilisation after TF-TAVI (MobiTAVI) trial

Speaker: Mr J. Vendrik (Amsterdam, NL)


The impact of residual mitral valve regurgitation on outcome after MitraClip therapy

Speaker: Doctor D. Reichart (Munich, DE)


Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using standardized new european definitions, a multicenter study

Speaker: Doctor A. Sokoloff (Rouen, FR)


6 month follow up results from the european transcatheter tricuspid valve repair multicenter trial

Speaker: Assistant Professor R. Von Bardeleben (Mainz, DE)


Panel discussion.


Access the full session

Advances in structural heart interventions

Speakers: Doctor A. Latib, Mr J. Vendrik, Doctor D. Reichart, Doctor A. Sokoloff, Assistant Professor R. Von Bardeleben

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb